Addressing the ADME Challenges of Compound Loss in a PDMS-Based Gut-on-Chip Microphysiological System

Authors:
Patrick Carius , Ferdinand Anton Weinelt , Chris Cantow , Markus Holstein , Aaron M Teitelbaum, Yunhai Cui 
In:
Source: Pharmaceutics
Publication Date: (2024)
Issue: 16: 296
Research Area:
Toxicology
Drug Discovery
Cells used in publication:
Endothelial, umbilical vein, human (HUVEC)
Species: human
Tissue Origin: vein
Experiment

Caco-2 cells (clone HTB-37) were obtained from the Leibniz Institute DSMZ-German Collection of Microorganisms Cell Cultures (Braunschweig, Germany), and primary human umbilical vein endothelial cells (HUVECs) from pooled donors were obtained from Lonza (Basel, Switzerland). Caco-2 cells were cultured in a T75 cm2 cell culture flask in 12 mL Dulbecco’s Modified Eagle Medium (DMEM) containing 20% fetal calf serum (FCS), 1% nonessential amino acids (NEAAs), 2 mM glutamine, and 100 U/mL penicillin, as well as 100 µg/mL streptomycin (Caco-2 culture medium), in a humidified incubator at 37 °C and 95% CO2. Subculturing was conducted after the cell layer reached ~80% confluency, usually every seven days. For subculturing, Caco-2 cells were washed with 10 mL PBS without magnesium or calcium before they were treated with 5 mL Accutase® (Merck, Darmstadt, Germany) for a maximum of 15 min or until all cells were detached. The enzymatic reaction was stopped with 8 mL Caco-2 culture medium, and the cells were centrifuged at 300 rcf for 5 min. Caco-2 cells were counted and 0.25 × 106 viable cells were seeded in a new T75 cm2 cell culture flask in 12 mL Caco-2 culture medium. All solutions, except for Accutase (room temperature), were warmed to 37 °C before use. Caco-2 cells were not used for more than 20 passages. HUVECs were handled similarly, with a few exceptions. The HUVECs were fed with 15 mL endothelial cell growth medium, with all supplements from Promocell (Heidelberg, Germany) including 2% FCS (HUVEC culture medium). In addition, the HUVECs were detached with Accutase solution for 5 min, and cells were only used from passages 2 to 6.

Abstract

Microphysiological systems (MPSs) are promising in vitro technologies for physiologically relevant predictions of the human absorption, distribution, metabolism, and excretion (ADME) properties of drug candidates. However, polydimethylsiloxane (PDMS), a common material used in MPSs, can both adsorb and absorb small molecules, thereby compromising experimental results. This study aimed to evaluate the feasibility of using the PDMS-based Emulate gut-on-chip to determine the first-pass intestinal drug clearance. In cell-free PDMS organ-chips, we assessed the loss of 17 drugs, among which testosterone was selected as a model compound for further study based on its substantial ad- and absorptions to organ chips and its extensive first-pass intestinal metabolism with well-characterized metabolites. A gut-on-chip model consisting of epithelial Caco-2 cells and primary human umbilical vein endothelial cells (HUVECs) was established. The barrier integrity of the model was tested with reference compounds and inhibition of drug efflux. Concentration-time profiles of testosterone were measured in cell-free organ chips and in gut-on-chip models. A method to deduce the metabolic clearance was provided. Our results demonstrate that metabolic clearance can be determined with PDMS-based MPSs despite substantial compound loss to the chip. Overall, this study offers a practical protocol to experimentally assess ADME properties in PDMS-based MPSs.